TrialThe Lancet. Neurology2025

Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial.

Kristy K L Coleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.